UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative Radiotherapy

被引：67

作者：

Diez, P. ^{[1
]}

Hanna, G. G. ^{[2
,3
]}

Aitken, K. L. ^{[4
,5
]}

van As, N. ^{[5
,6
]}

Carver, A. ^{[7
]}

Colaco, R. J. ^{[8
]}

Conibear, J. ^{[9
]}

Dunne, E. M. ^{[10
]}

Eaton, D. J. ^{[1
,11
,12
]}

Franks, K. N. ^{[13
]}

Good, J. S. ^{[14
]}

Harrow, S. ^{[15
]}

Hatfield, P. ^{[13
]}

Hawkins, M. A. ^{[16
,17
]}

Jain, S. ^{[2
,3
]}

McDonald, F. ^{[5
,6
]}

Patel, R. ^{[1
]}

Rackley, T. ^{[18
]}

Sanghera, P. ^{[14
]}

Tree, A. ^{[4
,6
]}

Murray, L. ^{[19
]}

机构：

[1] Mt Vernon Canc Ctr, Natl Radiotherapy Trials Qual Assurance Grp RTTQA, Radiotherapy Phys, Northwood, Middx, England

[2] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland

[3] Queens Univ Belfast, Belfast, Antrim, North Ireland

[4] Royal Marsden NHS Fdn Trust, Dept Radiotherapy, Sutton, Surrey, England

[5] Inst Canc Res, London, England

[6] Royal Marsden NHS Fdn Trust, Dept Radiotherapy, London, England

[7] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Med Ctr, Dept Med Phys, Birmingham, W Midlands, England

[8] Christie Hosp NHS Fdn Trust, Dept Clin Oncol, Manchester, Lancs, England

[9] Barts Canc Ctr, Radiotherapy Dept, London, England

[10] Guys & St Thomas NHS Fdn Trust, Dept Clin Oncol, London, England

[11] Guys & St Thomas NHS Fdn Trust, Dept Med Phys, London, England

[12] Kings Coll London, Sch Biomed Engn & Imaging Sci, London, England

[13] St James Univ Hosp, Dept Clin Oncol, Leeds Canc Ctr, Leeds, W Yorkshire, England

[14] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Dept Clin Oncol, Birmingham, W Midlands, England

[15] Western Gen Hosp, Edinburgh Canc Ctr, Dept Clin Oncol, Edinburgh, Midlothian, Scotland

[16] UCL, Dept Med Phys & Biomech Engn, London, England

[17] Univ Coll London Hosp NHS Fdn Trust, Dept Clin Oncol, London, England

[18] Velindre Canc Ctr, Dept Clin Oncol, Cardiff, Wales

[19] Univ Leeds, Leeds Inst Med Res & St Jamess, Leeds, W Yorkshire, England

来源：

CLINICAL ONCOLOGY | 2022年 / 34卷 / 05期

关键词：

Constraints; normal tissue; OAR; SABR; SBRT; stereotactic radiotherapy; BODY RADIATION-THERAPY; TOTAL MESORECTAL EXCISION; RECTAL-CANCER; RISK; ORGAN; RADIOSURGERY; FRACTION; TUMORS; SABR; HYPOFRACTIONATION;

D O I：

10.1016/j.clon.2022.02.010

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past decade, in part as the result of several UK clinical trials and a recent NHS England Commissioning through Evaluation programme. A UK SABR Consortium consensus for normal tissue constraints for SABR was published in 2017, based on the existing literature at the time. The published literature regarding SABR has increased in volume over the past 5 years and multiple UK centres are currently working to develop new SABR services. A review and update of the previous consensus is therefore appropriate and timely. It is hoped that this document will provide a useful resource to facilitate safe and consistent SABR practice. (C) 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

引用

页码：288 / 300

页数：13

共 57 条

[1] LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective
Adebahr, S.
Collette, S.
Shash, E.
Lambrecht, M.
Le Pechoux, C.
Faivre-Finn, C.
De Ruysscher, D.
Peulen, H.
Belderbos, J.
Dziadziuszko, R.
Fink, C.
Guckenberger, M.
Hurkmans, C.
Nestle, U.
[J]. BRITISH JOURNAL OF RADIOLOGY, 2015, 88 (1051)
[2] [Anonymous], 2019, CONV CAR VERS RAD ST
[3] [Anonymous], 2021, ABC07 CANC RES UK
[4] [Anonymous], 2018, STEREOTACTIC BODY RA
[5] Stereotactic body radiation therapy: The report of AAPM Task Group 101
Benedict, Stanley H.
Yenice, Kamil M.
Followill, David
Galvin, James M.
Hinson, William
Kavanagh, Brian
Keall, Paul
Lovelock, Michael
Meeks, Sanford
Papiez, Lech
Purdie, Thomas
Sadagopan, Ramaswamy
Schell, Michael C.
Salter, Bill
Schlesinger, David J.
Shiu, Almon S.
Solberg, Timothy
Song, Danny Y.
Stieber, Volker
Timmerman, Robert
Tome, Wolfgang A.
Verellen, Dirk
Wang, Lu
Yin, Fang-Fang
[J]. MEDICAL PHYSICS, 2010, 37 (08) : 4078 - 4101
[6] Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Brand, Douglas H.
Tree, Alison C.
Ostler, Peter
van der Voet, Hans
Loblaw, Andrew
Chu, William
Ford, Daniel
Tolan, Shaun
Jain, Suneil
Martin, Alexander
Staffurth, John
Camilleri, Philip
Kancherla, Kiran
Frew, John
Chan, Andrew
Dayes, Ian S.
Henderson, Daniel
Brown, Stephanie
Cruickshank, Clare
Burnett, Stephanie
Duffton, Aileen
Griffin, Clare
Hinder, Victoria
Morrison, Kirsty
Naismith, Olivia
Hall, Emma
van As, Nicholas
[J]. LANCET ONCOLOGY, 2019, 20 (11) : 1531 - 1543
[7] Chalkidou A, 2021, LANCET ONCOL, V22, P98, DOI 10.1016/S1470-2045(20)30537-4
[8] Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Chang, Joe Y.
Senan, Suresh
Paul, Marinus A.
Mehran, Reza J.
Louie, Alexander V.
Balter, Peter
Groen, Harry J. M.
McRae, Stephen E.
Widder, Joachim
Feng, Lei
van den Borne, Ben E. E. M.
Munsell, Mark F.
Hurkmans, Coen
Berry, Donald A.
van Werkhoven, Erik
Kresl, John J.
Dingemans, Anne-Marie
Dawood, Omar
Haasbeek, Cornelis J. A.
Carpenter, Larry S.
De Jaeger, Katrien
Komaki, Ritsuko
Slotman, Ben J.
Smit, Egbert F.
Roth, Jack A.
[J]. LANCET ONCOLOGY, 2015, 16 (06) : 630 - 637
[9] clinicaltrials, SABRCOMET3
[10] Dose escalation for locally advanced pancreatic cancer: How high can we go?
Colbert, Lauren E.
Rebueno, Neal
Moningi, Shalini
Beddar, Sam
Sawakuchi, Gabriel O.
Herman, Joseph M.
Koong, Albert C.
Das, Prajnan
Holliday, Emma B.
Koay, Eugene J.
Taniguchi, Cullen M.
[J]. ADVANCES IN RADIATION ONCOLOGY, 2018, 3 (04) : 693 - 700

← 1 2 3 4 5 6 →